- Home
- BCSF vs NKTR Comparison
BCSF vs NKTR Comparison
Compare BCSF & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BCSF | NKTR |
|---|---|---|
| Founded | 2015 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 896.5M | 807.8M |
| IPO Year | 2018 | 1994 |
Fundamental Metrics
Financial Performance| Metric | BCSF | NKTR |
|---|---|---|
| Price | $13.64 | $37.50 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | $15.00 | ★ $111.83 |
| AVG Volume (30 Days) | 391.6K | ★ 701.9K |
| Earning Date | 02-26-2026 | 03-11-2026 |
| Dividend Yield | ★ 13.20% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.44 | N/A |
| Revenue | ★ $278,347,000.00 | $62,600,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $9.48 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.20 | $6.48 |
| 52 Week High | $19.21 | $66.92 |
Technical Indicators
Market Signals| Indicator | BCSF | NKTR |
|---|---|---|
| Relative Strength Index (RSI) | 44.47 | 36.82 |
| Support Level | $13.46 | $35.03 |
| Resistance Level | $13.87 | $38.29 |
| Average True Range (ATR) | 0.28 | 2.32 |
| MACD | -0.02 | 0.20 |
| Stochastic Oscillator | 20.22 | 26.05 |
Price Performance
Historical ComparisonAbout BCSF Bain Capital Specialty Finance Inc.
Bain Capital Specialty Finance Inc is an externally managed, closed-end, non-diversified management investment company. The company's objective is to provide risk-adjusted returns and current income to investors by investing predominantly in middle-market companies with between $10.0 million and $150.0 million in annual EBITDA. Its portfolio of investments includes First Lien Senior Secured Loan, Preferred Equity, Equity Interest, Warrants, and Second Lien Senior Secured Loan among others.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.